Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
Worth Seeing!
Transform your wealth with Omega. Exclusive consultation awaits.Schedule Meeting!
Schedule Meeting!
BSE: 506687 | NSE: TRANSPEK | Pesticides & Agrochemicals | Small Cap
Past 10 year's financial track record analysis by Moneyworks4me indicates that Transpek Industry Ltd is a good quality company.
The key valuation ratios of Transpek Industry Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transpek Industry Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 18% | 27.6% | 23% | 12.6% | 26.6% | 24.3% | 7.8% | 17.4% | 20.7% | 10.1% | - |
| Value Creation Index ⓘ | 0.3 | 1.0 | 0.6 | -0.1 | 0.9 | 0.7 | -0.4 | 0.3 | 0.5 | -0.3 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 259 | 284 | 317 | 361 | 595 | 566 | 339 | 599 | 827 | 580 | 569 |
| Sales YoY Gr. | - | 9.4% | 11.6% | 14.1% | 64.6% | -4.9% | -40% | 76.5% | 38% | -29.9% | - |
| Adj EPS ⓘ | 18.2 | 35.1 | 52.9 | 46 | 117.9 | 132.3 | 41 | 118 | 160.7 | 68.1 | 57.3 |
| YoY Gr. | - | 92.9% | 50.5% | -13% | 156.2% | 12.2% | -69% | 187.8% | 36.2% | -57.6% | - |
| BVPS (₹) ⓘ | 127.3 | 154.5 | 368.1 | 442.1 | 557.5 | 605.9 | 680 | 867.1 | 1,050.3 | 1,205.6 | 1,222.3 |
| Adj Net Profit ⓘ | 10.7 | 20.6 | 29.5 | 25.7 | 65.8 | 73.9 | 22.9 | 65.9 | 89.8 | 38.1 | 32 |
| Cash Flow from Ops. ⓘ | 9.7 | 43.9 | 47 | 7.4 | 128 | 111 | 34.4 | 47.1 | 111 | 97.8 | - |
| Debt/CF from Ops. ⓘ | 8 | 1.5 | 1.9 | 27.6 | 1.1 | 1 | 2.8 | 2.7 | 0.7 | 0.5 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 9.4% | -0.5% | 19.5% | -29.9% | ||||
| Adj EPS ⓘ | 15.8% | -10.4% | 18.4% | -57.6% | ||||
| BVPSⓘ | 28.4% | 16.7% | 21% | 14.8% | ||||
| Share Price | 21.5% | 6% | -11.1% | -10.4% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 15.1 | 24.9 | 19.9 | 11.4 | 23.6 | 22.7 | 6.4 | 15.3 | 16.8 | 6 | 4.7 |
| Op. Profit Mgn % ⓘ | 12.4 | 17 | 16.9 | 13.1 | 19.7 | 21.1 | 14.1 | 17 | 19 | 14.2 | 13.3 |
| Net Profit Mgn % ⓘ | 4.1 | 7.3 | 9.3 | 7.1 | 11.1 | 13.1 | 6.8 | 11 | 10.9 | 6.6 | 5.6 |
| Debt to Equity ⓘ | 1 | 0.7 | 0.4 | 0.8 | 0.5 | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 | - |
| Working Cap Days ⓘ | 161 | 136 | 123 | 156 | 112 | 111 | 160 | 104 | 97 | 140 | 70 |
| Cash Conv. Cycle ⓘ | 62 | 69 | 65 | 70 | 44 | 48 | 82 | 53 | 47 | 71 | 32 |
Sales growth is growing at healthy rate in last 3 years 19.53%
Net Profit is growing at healthy rate in last 3 years 18.44%
Return on Equity has declined versus last 3 years average to 4.70%
Sales growth is not so good in last 4 quarters at -25.46%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 57.3 | 57.3 |
| TTM Sales (₹ Cr.) | 569 | 569 |
| BVPS (₹.) ⓘ | 1,222.3 | 1,222.2 |
| Reserves (₹ Cr.) ⓘ | 677 | 677 |
| P/BV ⓘ | 1.37 | 1.37 |
| PE ⓘ | 29.24 | 29.24 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 1510.00 / 2185.00 |
| All Time Low / High (₹) | 6.90 / 2695.00 |
| Market Cap (₹ Cr.) | 936 |
| Equity (₹ Cr.) | 5.6 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 42.2 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 259 | 284 | 317 | 361 | 595 | 566 | 339 | 599 | 827 | 580 |
| Operating Expenses ⓘ | 228 | 237 | 264 | 314 | 478 | 448 | 292 | 503 | 680 | 497 |
| Manufacturing Costs | 29 | 35 | 34 | 38 | 59 | 67 | 46 | 65 | 76 | 71 |
| Material Costs | 130 | 124 | 149 | 192 | 301 | 260 | 163 | 315 | 438 | 287 |
| Employee Cost | 28 | 32 | 35 | 37 | 45 | 49 | 44 | 51 | 60 | 62 |
| Other Costs ⓘ | 41 | 45 | 46 | 47 | 73 | 71 | 40 | 72 | 106 | 77 |
| Operating Profit ⓘ | 31 | 47 | 53 | 47 | 117 | 118 | 47 | 96 | 147 | 82 |
| Operating Profit Margin (%) | 12.0% | 16.5% | 16.6% | 13.0% | 19.6% | 20.8% | 13.9% | 16.0% | 17.8% | 14.2% |
| Other Income ⓘ | 5 | 4 | 7 | 10 | 18 | 17 | 17 | 29 | 18 | 25 |
| Interest ⓘ | 12 | 11 | 9 | 12 | 19 | 16 | 10 | 11 | 19 | 14 |
| Depreciation ⓘ | 9 | 8 | 9 | 10 | 14 | 26 | 29 | 30 | 33 | 38 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 16 | 32 | 42 | 35 | 101 | 94 | 26 | 84 | 113 | 56 |
| Tax ⓘ | 5 | 10 | 12 | 9 | 36 | 21 | 2 | 19 | 29 | 17 |
| Profit After Tax | 11 | 21 | 30 | 26 | 66 | 73 | 23 | 65 | 83 | 39 |
| PAT Margin (%) | 4.3% | 7.5% | 9.5% | 7.3% | 11.1% | 12.9% | 6.9% | 10.9% | 10.1% | 6.7% |
| Adjusted EPS (₹) | 18.8 | 36.2 | 53.7 | 47.3 | 117.7 | 130.6 | 41.7 | 117.1 | 149.5 | 69.0 |
| Dividend Payout Ratio (%) | 27% | 21% | 17% | 19% | 17% | 10% | 18% | 19% | 18% | 20% |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 75 | 91 | 206 | 247 | 311 | 338 | 380 | 484 | 587 | 673 |
| Share Capital ⓘ | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves ⓘ | 69 | 85 | 200 | 241 | 306 | 333 | 374 | 479 | 581 | 668 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 72 | 56 | 70 | 180 | 120 | 77 | 71 | 105 | 63 | 30 |
| Long Term Debt | 30 | 26 | 25 | 85 | 69 | 45 | 44 | 35 | 28 | 20 |
| Short Term Debt | 42 | 30 | 45 | 95 | 51 | 32 | 27 | 70 | 35 | 10 |
| Trade Payables | 46 | 20 | 34 | 54 | 59 | 52 | 36 | 56 | 54 | 46 |
| Others Liabilities ⓘ | 37 | 42 | 77 | 85 | 108 | 121 | 112 | 118 | 183 | 217 |
| Total Liabilities ⓘ | 229 | 209 | 386 | 566 | 599 | 589 | 599 | 764 | 887 | 966 |
Fixed Assets | ||||||||||
| Gross Block | 173 | 180 | 126 | 197 | 268 | 343 | 370 | 380 | 465 | 530 |
| Accumulated Depreciation | 80 | 86 | 9 | 19 | 32 | 56 | 83 | 85 | 100 | 133 |
| Net Fixed Assetsⓘ | 92 | 94 | 117 | 179 | 236 | 287 | 287 | 295 | 365 | 397 |
| CWIP ⓘ | 5 | 10 | 13 | 56 | 33 | 19 | 14 | 16 | 24 | 6 |
| Investmentsⓘ | 5 | 5 | 131 | 144 | 149 | 118 | 142 | 196 | 238 | 321 |
| Inventories | 27 | 38 | 37 | 46 | 56 | 50 | 37 | 66 | 65 | 64 |
| Trade Receivables | 82 | 46 | 67 | 93 | 93 | 90 | 76 | 99 | 118 | 92 |
| Cash Equivalents | 2 | 4 | 1 | 2 | 1 | 1 | 22 | 51 | 25 | 31 |
| Others Assetsⓘ | 15 | 12 | 20 | 47 | 30 | 25 | 21 | 41 | 51 | 55 |
| Total Assets ⓘ | 229 | 209 | 386 | 566 | 599 | 589 | 599 | 764 | 887 | 966 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 10 | 44 | 47 | 7 | 128 | 111 | 34 | 47 | 111 | 98 |
| PBT ⓘ | 16 | 32 | 42 | 35 | 101 | 94 | 26 | 84 | 113 | 56 |
| Adjustment ⓘ | 18 | 19 | 13 | 19 | 30 | 39 | 34 | 35 | 56 | 41 |
| Changes in Working Capital ⓘ | -23 | -1 | 2 | -36 | 16 | 2 | -21 | -50 | -22 | 13 |
| Tax Paid ⓘ | -1 | -6 | -10 | -10 | -20 | -24 | -4 | -23 | -36 | -12 |
| Cash Flow From Investing Activity ⓘ | -1 | -16 | -31 | -103 | -45 | -33 | -17 | -70 | -13 | -32 |
| Capex | -8 | -17 | -37 | -119 | -47 | -37 | -14 | -38 | -45 | -38 |
| Net Investments | 4 | 0 | 0 | 13 | 0 | 0 | -6 | -43 | 30 | -2 |
| Others ⓘ | 3 | 1 | 6 | 3 | 3 | 3 | 4 | 11 | 2 | 9 |
| Cash Flow From Financing Activityⓘ | -8 | -27 | -17 | 96 | -83 | -77 | -3 | 9 | -94 | -64 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 10 | 65 | -16 | -17 | 0 | -10 | -7 | -8 |
| Interest Paid ⓘ | -13 | -10 | -8 | -12 | -18 | -13 | -9 | -9 | -13 | -10 |
| Dividend Paid ⓘ | -1 | -3 | -5 | -6 | -6 | -20 | -1 | -4 | -13 | -15 |
| Others ⓘ | 6 | -14 | -13 | 49 | -43 | -26 | 8 | 32 | -61 | -30 |
| Net Cash Flow ⓘ | 0 | 1 | -1 | 0 | 0 | 0 | 15 | -14 | 4 | 3 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 15.57 | 25.71 | 20.23 | 11.67 | 23.55 | 22.45 | 6.49 | 15.14 | 15.59 | 6.12 |
| ROCE (%) | 18 | 27.58 | 22.98 | 12.62 | 26.57 | 24.27 | 7.81 | 17.43 | 20.66 | 10.11 |
| Asset Turnover Ratio | 1.19 | 1.35 | 1.1 | 0.76 | 1.02 | 0.95 | 0.57 | 0.88 | 1 | 0.63 |
| PAT to CFO Conversion(x) | 0.91 | 2.1 | 1.57 | 0.27 | 1.94 | 1.52 | 1.48 | 0.72 | 1.34 | 2.51 | Working Capital Days |
| Receivable Days | 101 | 79 | 63 | 81 | 57 | 59 | 89 | 53 | 48 | 66 |
| Inventory Days | 37 | 40 | 42 | 42 | 31 | 34 | 46 | 31 | 29 | 41 |
| Payable Days | 127 | 97 | 66 | 84 | 69 | 78 | 99 | 54 | 46 | 64 |
Transpek Industry was set up in 1965 initially for manufacturing transparent acrylic sheets. The company has grown to become one of the leading manufacturers and exporters of a range of chemicals servicing the requirements of customers from a diverse range of industries - textiles, pharmaceuticals, agrochemicals, polymers, etc.
Transpek has evolved as a ‘first time’ manufacturer of several products in India and also pioneered the development of the market for the same.
With its expertise in handling chlorine and sulphur, the company has indigenously developed a process for chlorinated chemicals like Thionyl Chloride and Chloro Acetyl Chloride. Today the capacity for thionyl chloride at Transpek is the largest outside Europe.
Transpek used to manufacture sodium hydro sulphite, safolite, safoline, zinc oxide and zinc dust. This business since has been transferred to Transpek Silox Industry, a joint venture between Transpek & Silox.
Products
• Thionyl Chloride: 15000 TPA
• Chloro Acetyl Chloride: 900 TPA
• Sulphur Dichloride: 1500 TPA
• Sulphur Monochloride: 7500 TPA
• Oleum 65% : 12000 TPA
• Sulphur Trioxide: 10000 TPA
• Sulphuric Acid: 5000 TPA
• Sulphur Dioxide: 7500 TPA
• Acid Chlorides: 1200 TPA
Milestones
• In 1989, all members of Transpek received equity shares at face value, when the market price was over 20 times.
• In 1990, the company won a turnkey project in Iran to install and commission a chemical plant valuing $12.5 million, against competition from several world players.
• 1992, Financial Express, a leading Indian business daily, declared Transpek as the ‘Best Inorganic Chemical Company’ for two consecutive years.
• In 1996 Transpek commissioned the world’s largest manufacturing facility for Thionyl Chloride outside Europe.
• In 1997, its quality management system was awarded with ISO 9002 recognition from RWTUV of Germany.
• Transpek was recognized by the Government of India as an Export House.
• In 2000, the company’s quality management system was awarded ISO 14001 recognition from RWTUV of Germany
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
